Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.38 USD | +0.02% | -0.02% | +57.32% |
05-01 | North American Morning Briefing : Traders Wait for -2- | DJ |
04-30 | Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.32% | 2.09B | |
+3.75% | 108B | |
+11.13% | 104B | |
+1.28% | 22.33B | |
-12.86% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.69% | 17.64B | |
+3.64% | 14.05B | |
+37.33% | 12.51B |
- Stock Market
- Equities
- DCPH Stock
- News Deciphera Pharmaceuticals, Inc.
- Piper Sandler Upgrades Deciphera Pharmaceuticals to Overweight From Neutral, Raises Price Target to $23 From $18